The molecular and genetic basis of neurological tumours.
about
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressorRGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrestTumor microenvironment and neurofibromatosis type I: connecting the GAPsBcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastomaEffect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and RasTranscriptional signature of an adult brain tumor in DrosophilaROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic StrategiesGene therapy for brain tumors: basic developments and clinical implementationMetagenomics: A new horizon in cancer researchGrowth of peripheral and central nervous system tumors is supported by cytoplasmic c-Fos in humans and miceSuperbinder SH2 domains act as antagonists of cell signalingBmi-1 promotes glioma angiogenesis by activating NF-κB signalingCoordinated control of self-renewal and differentiation of neural stem cells by Myc and the p19ARF-p53 pathwayCell of origin for malignant gliomas and its implication in therapeutic developmentThe p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses.A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype.Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.Notch signaling in glioblastoma: a developmental drug target?Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cellsGenome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomasControlling cytoplasmic c-Fos controls tumor growth in the peripheral and central nervous system.SV40 in human brain cancers and non-Hodgkin's lymphoma.MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.Gliomagenesis and the use of neural stem cells in brain tumor treatmentBmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway.Mouse models of inherited cancer syndromesBrain neoplasms and coagulation-lessons from heterogeneity.Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection.Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours.ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas.TWIST is expressed in human gliomas and promotes invasion.Polish natural bee honeys are anti-proliferative and anti-metastatic agents in human glioblastoma multiforme U87MG cell lineAstrocyte elevated gene-1: a novel target for human glioma therapy.The PI3K-Akt pathway inhibits senescence and promotes self-renewal of human skin-derived precursors in vitro.Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors
P2860
Q24299628-01F12F02-5F1E-4B60-869A-F9DA3D3AA735Q24322861-F263604C-B339-4E7F-9FA5-C945F42A39A4Q24654681-88A37276-D138-4005-B027-3C8F1D8E030BQ24670606-1CBA9D36-A72F-48D0-9068-65FB23F2CECFQ24671862-811730CA-B184-4AAE-9F30-97185E399A88Q24804293-BBBB8B2B-7DFE-45F1-B220-AFABC465FD29Q26747496-4AA63860-119B-4B72-B4C6-F8FFD2DA3078Q26829086-3036A5EB-B7DC-46AF-965E-0BBD88531666Q26999877-5BA2F016-D744-4ED1-9A9F-26AF11F3A656Q27333591-66CED605-206F-483E-8CE4-C3019228DC19Q27682496-50E53A56-A9DA-496A-917D-3D8C37AE5EFDQ28485863-83F881C6-2A8C-49FA-B1AF-7B9C2F161217Q28581842-1D22A134-EC6E-47A0-A5C2-FA7DE69CDE0BQ30300877-C6CBE41B-E4CD-487F-AE76-DDE4F2DE2DA6Q30412209-5B9890CC-6B5E-4096-B06F-433F145062DEQ30579545-41639F5F-8408-4269-9D30-6A5D6F61A4D3Q33325737-C2FFE3EB-9773-4D37-9619-D5AEFCCB0657Q33733341-74258AF8-D40E-4E09-A3CE-31768584CE8DQ33747041-3BA6B8ED-765A-49F5-BD68-89F1499CFE85Q33828114-66D6DA72-D8DD-4E80-BFEB-D25FFF89BD1AQ33941052-7DB82D26-F492-492D-A866-E4C159AD12A6Q34132699-2356D684-7FE8-489F-BF88-C0C200053258Q34220666-9B0858CF-FCD2-4637-81EB-42F6D3E41946Q34221199-0E19270D-1467-49E2-ADA0-2716C1DF6F67Q34221882-FEE91366-F991-4EAB-A3E9-FCF9E8AC458BQ34310698-F0E6DF71-9466-4535-9B5D-F110C3C2DEBFQ34411179-4E8DC519-A46C-4AD2-8095-CA82B47A71E7Q34447472-5507AEE3-EA36-46DD-A330-C2767FB18328Q34463432-FC9DC3B6-04F6-4EA8-9D9E-AF42F3CCB956Q34467060-E6F20F88-EC77-4395-AE04-7B776E57E13CQ34509145-E14F15E4-8CCD-461C-81B1-4AB19DE26158Q34575813-EBFDC259-2D94-4F24-BF79-B3270BD3FD97Q34621019-C299F298-9294-4404-BA0A-2485E6124FD4Q34625129-7ABD6401-7742-4BFD-B1A1-443F85C79BE0Q34734481-C86B65B7-5B61-4114-A242-58586EE94D7EQ34769731-1D789B49-3D6B-4328-876F-F4731C8055A0Q35110867-E727207C-28B7-4290-BB79-ABD86A7B557FQ35190515-A405FD7A-35BB-437F-8C58-96C8020524F6Q35347580-431AF4C8-A021-4E88-AE59-10C64F66C917Q35545648-BFEB03F7-BC1A-424F-B707-3118410978AA
P2860
The molecular and genetic basis of neurological tumours.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The molecular and genetic basis of neurological tumours.
@ast
The molecular and genetic basis of neurological tumours.
@en
The molecular and genetic basis of neurological tumours.
@nl
type
label
The molecular and genetic basis of neurological tumours.
@ast
The molecular and genetic basis of neurological tumours.
@en
The molecular and genetic basis of neurological tumours.
@nl
prefLabel
The molecular and genetic basis of neurological tumours.
@ast
The molecular and genetic basis of neurological tumours.
@en
The molecular and genetic basis of neurological tumours.
@nl
P356
P1476
The molecular and genetic basis of neurological tumours.
@en
P2093
Luis F Parada
P2888
P304
P356
10.1038/NRC866
P407
P577
2002-08-01T00:00:00Z
P6179
1019690281